Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ANTARES PHARMA (NQ: ATRS)
4.050 USD  +0.090 (+2.27%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about ANTARES PHARMA
 
< Previous 1 2 3 4 5 6 Next >
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
July 08, 2009
from Business Wire News Releases
NAI500 announces July additions to the 500 list
July 02, 2009
from PR Newswire
The following is an investment opinion release issued by Pennystockchaser.com
June 29, 2009
from PR Newswire
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin® (Human Growth Hormone)
June 29, 2009
from Business Wire News Releases
Antares Pharma Announces Partners Update of LibiGel® Safety Study
June 17, 2009
from Business Wire News Releases
Antares Pharma, Inc. to Present at 8th Annual Needham Life Sciences Conference
June 08, 2009
from Business Wire News Releases
Antares Pharma, Inc. to Present at Noble Financial’s Fifth Annual Equity Conference
June 05, 2009
from Business Wire News Releases
Antares Pharma Receives NYSE Amex Notification
June 04, 2009
from Business Wire News Releases
Antares Pharma Reports First Quarter 2009 Financial and Operating Results
May 13, 2009
from Business Wire News Releases
Antares Pharma to Host First Quarter 2009 Earnings Call
April 29, 2009
from Business Wire News Releases
Antares Pharma Announces Going Concern Qualification
March 27, 2009
from Business Wire News Releases
Antares Pharma Reports Ferring Pharmaceuticals Receives Frost and Sullivan European Human Growth Hormone Competitive Strategy Leadership Award for ZomaJet Needle Free Injection
March 26, 2009
from Business Wire News Releases
Antares Pharma Reports Fourth Quarter and Year End 2008 Financial and Operating Results
March 25, 2009
from Business Wire News Releases
Antares Pharma to Host Fourth Quarter and Year-End 2008 Earnings Call
March 10, 2009
from Business Wire News Releases
Antares to Present at Cowen and Company 29th Annual Health Care Conference
March 09, 2009
from Business Wire News Releases
Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing
January 22, 2009
from Business Wire News Releases
Antares Pharma Receives Milestone Payment and Additional Patent Related to Elestrin®
January 06, 2009
from Business Wire News Releases
Antares Pharma and Population Council Announce Initiation of Phase II Clinical Trial for a Novel Contraceptive ATD Gel
November 24, 2008
from Business Wire News Releases
Antares Pharma Reports Recent Developments and Third Quarter 2008 Financial Results
November 13, 2008
Highlights -- Appointed Paul K. Wotton, Ph.D., as President and Chief Executive Officer -- Appointed Leonard S. Jacob, M.D., Ph.D., as Chairman of the Board of Directors -- Revenues from product sales... Read More
from Business Wire News Releases
Antares Announces Additional Regulatory Approvals in Europe and Australia for Its Needle-Free Injection Device
November 05, 2008
from Business Wire News Releases
Antares Pharma Appoints Dr. Leonard S. Jacob as Chairman of the Board
October 13, 2008
Dr. Jacques Gonella to Continue as Director Read More
from Business Wire News Releases
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
October 13, 2008
from Business Wire News Releases
Antares Pharma Enters Into a Feasibility Development Agreement with Dr. Reddy's Laboratories, Inc. for an Enhanced Dermatology Product Utilizing the ATD Gel Platform
September 03, 2008
from Business Wire News Releases
Antares Pharma Reports Second Quarter 2008 Financial Results
August 14, 2008
from Business Wire News Releases
Antares Pharma to Report 2008 Second Quarter Financial Results on August 14, 2008
August 05, 2008
from Business Wire News Releases
*Revised* Analyst Reports for Evergreen Energy Inc., Antares Pharma Inc., Credit Suisse High Yield Bond Fund, and InterDigital Inc.
July 30, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach Read More
from Marketwired News Releases
Antares Pharma and Teva Announce Filing of sNDA for Needle-Free Injector with Human Growth Hormone
July 29, 2008
from Business Wire News Releases
Antares Pharma to Present at the BMO Capital Markets Healthcare Conference
July 17, 2008
from Business Wire News Releases
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
July 07, 2008
from Business Wire News Releases
Antares Receives a Notice of Allowance for U.S. Patent Covering Anturol(TM)
June 04, 2008
from Business Wire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here